Fungal infections are on the rise globally. According to a study by the Manchester Fungal Infection Group, in 2022, ...

Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA ...

RNA-based therapeutics are gaining traction due to advancements in delivery technologies, despite historical challenges with ...

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top ...

Korro Bio's OPERA platform offers precise RNA editing for genetic diseases like Alpha-1 antitrypsin deficiency. Learn more on ...

New RNA-based active agents reliably protect plants against the Cucumber mosaic virus (CMV), the most common virus in ...

Bioluminescent luciferase enzymes have historically been too dim to use as probes in living tissue. But recent advances have ...

Scientists at the UCLA Health Jonsson Comprehensive Cancer Center and the University of Toronto have revealed how a tiny ...

CHICAGO — Lepodisiran, a small interfering RNA agent, lowered lipoprotein(a) levels at 180 days, with a reduction of more ...

A single dose of an experimental drug dramatically reduced levels of a deadly form of cholesterol, often thought to be ...

Researchers at Martin Luther University have developed groundbreaking RNA-based agents that offer high levels of protection ...

Quantbot Technologies LP acquired a new position in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) during the ...